A Prospective, Open-label Trial of Two Abacavir/Lamivudine Based Regimen (ABC/3TC + Darunavir/Ritonavir or ABC/3TC + Raltegravir) in Late Presenter naïve Patients (With CD4 Count <200 Cells/µL - Advanced HIV Disease)

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified July 2013 by University of Modena and Reggio Emilia
Sponsor:
Information provided by (Responsible Party):
Cristina Mussini, University of Modena and Reggio Emilia
ClinicalTrials.gov Identifier:
NCT01900106
First received: July 5, 2013
Last updated: July 11, 2013
Last verified: July 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)